Delivery of Osteogenic Regulatory Growth Factors - Engineered Bone: Tissue Engineering Intelligence Unit - page 122

58. Alam I, Asahina I, Ohmamiuda K et al. Comparative study of biphasic calcium phosphate ceram-
ics impregnated with rhBMP-2 as bone substitutes. J Biomed Mater Res 2001; 54:129-38.
59. Gao TJ, Lindholm TS, Kommonen B et al. Enhanced healing of segmental tibial defects in sheep
by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic
protein, and type IV collagen. J Biomed Mater Res 1996; 32:505-12.
60. Ripamonti U. The induction of bone in osteogenic composites of bone matrix and porous hy-
droxyapatite replicas: An experimental study on the baboon (Papio ursinus). J Oral Maxillofac
Surg 1991; 49:817-30.
61. Gao TJ, Lindholm TS, Kommonen B et al. The use of a coral composite implant containing bone
morphogenetic protein to repair a segmental tibial defect in sheep. Int Orthop 1997; 21:194-200
62. Tuominen T, Jamsa T, Tuukkanen J et al. Native bovine bone morphogenetic protein improves
the potential of biocoral to heal segmental canine ulnar defects. Int Orthop 2000; 24:289-94.
63. Arnaud E, De Pollak C, Meunier A et al. Osteogenesis with coral is increased by BMP and BMC
in a rat cranioplasty. Biomaterials 1999; 20:1909-18.
64. YamazakiY, Oida S, Akimoto Y et al. Response of the mouse femoral muscle to an implant of a
composite of bone morphogenetic protein and plaster of Paris. Clin Orthop 1988; 240-9.
65. Katoh T, Sato K, Kawamura M et al. Osteogenesis in sintered bone combined with bovine bone
morphogenetic protein. Clin Orthop 1993; 266-75.
66. Pajamaki KJ, Andersson OH, Lindholm TS et al. Effect of bovine bone morphogenetic protein
and bioactive glass on demineralized bone matrix grafts in the rat muscular pouch. Ann Chir
Gynaecol Suppl 1993; 207:155-61
67. Nicoll SB, Radin S, Santos EM et al. Ducheyne. In vitro release kinetics of biologically active
transforming growth factor-beta 1 from a novel porous glass carrier. Biomaterials 1997; 18:853-9.
68. Ijiri S, Nakamura T, Fujisawa Y et al. Ectopic bone induction in porous apatite-wollastonite-containing
glass ceramic combined with bone morphogenetic protein. J Biomed Mater Res 1997; 35:421-32.
69. Guillemin G, Patat JL, Fournie J et al. The use of coral as a bone graft substitute. J Biomed Mater
Res 1987; 21:557-67.
70. Demers CN, Tabrizian M, Petit A et al. Effect of experimental parameters on the in vitro release
kinetics of transforming growth factor beta1 from coral particles. J Biomed Mater Res 2002;
59:403-10.
71. Van de Putte KA, Urist MR. Osteogenesis in the interior of intramuscular implants of decalcified
bone matrix. Clin Orthop 1965; 43:257-70.
72. Solheim E. Osteoinduction by demineralised bone. Int Orthop 1998; 22:335-42
73. Marden LJ, Quigley NC, Reddi AH et al. Temporal changes during bone regeneration in the
calvarium induced by osteogenin. Calcif Tissue Int 1993; 53:262-8.
74. Mark DE, Hollinger JO, Hastings Jr C et al. Repair of calvarial nonunions by osteogenin, a
bone-inductive protein. Plast Reconstr Surg 1990; 86:623-30; discussion 631-2.
75. Marden LJ, Hollinger JO, Chaudhari A et al. Recombinant human bone morphogenetic protein-2
is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater
Res 1994; 28:1127-38.
76. Bosquey AL. Osteopontin and related phosphorylated sialoproteins: Effects on mineralization. Ann
N Y Acad Sci 1995; 21:249-256
77. Niederwanger M, Urist MR. Demineralized bone matrix supplied by bone banks for a carrier of
recombinant human bone morphogenetic protein (rhBMP-2): A substitute for autogeneic bone
grafts. J Oral Implantol 1996; 22:210-5.
78. Schwartz Z, Somers A, Mellonig JT et al. Addition of human recombinant bone morphogenetic
protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effec-
tive composite bone inductive implant material. J Periodontol 1998; 69:1337-45.
79. Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in basic sciences. The use of an
osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species.
Spine 1995; 20:2633-44.
80. DeLustro F, Dasch J, Keefe J et al. Immune responses to allogeneic and xenogeneic implants of
collagen and collagen derivatives. Clin Orthop 1990; 263-79.
81. Chvapil M. Collagen sponge: Theory and practice of medical applications. J Biomed Mater Res
1977; 11:721-41.
82. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix compo-
nents involved in local bone differentiation. Proc Natl Acad Sci USA 1981; 78:7599-603.
83. Hubbell JA. Biomaterials in tissue engineering. Biotechnology (NY) 1995; 13:565-76.
84. Sciadini MF, Johnson KD. Evaluation of recombinant human bone morphogenetic protein-2 as a
bone- graft substitute in a canine segmental defect model. J Orthop Res 2000; 18:289-302.
85. Boyne PJ, Nath R Nakamura A. Human recombinant BMP-2 in osseous reconstruction of simu-
lated cleft palate defects. Br J Oral Maxillofac Surg 1998; 36:84-90.